1,386 reports of this reaction
1.2% of all ACETAMINOPHEN AND CODEINE reports
#18 most reported adverse reaction
NASOPHARYNGITIS is the #18 most commonly reported adverse reaction for ACETAMINOPHEN AND CODEINE, manufactured by Amneal Pharmaceuticals LLC. There are 1,386 FDA adverse event reports linking ACETAMINOPHEN AND CODEINE to NASOPHARYNGITIS. This represents approximately 1.2% of all 113,152 adverse event reports for this drug.
Patients taking ACETAMINOPHEN AND CODEINE who experience nasopharyngitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NASOPHARYNGITIS is a less commonly reported adverse event for ACETAMINOPHEN AND CODEINE, but still significant enough to appear in the safety profile.
In addition to nasopharyngitis, the following adverse reactions have been reported for ACETAMINOPHEN AND CODEINE:
The following drugs have also been linked to nasopharyngitis in FDA adverse event reports:
NASOPHARYNGITIS has been reported as an adverse event in 1,386 FDA reports for ACETAMINOPHEN AND CODEINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NASOPHARYNGITIS accounts for approximately 1.2% of all adverse event reports for ACETAMINOPHEN AND CODEINE, making it a notable side effect.
If you experience nasopharyngitis while taking ACETAMINOPHEN AND CODEINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.